Machiko Umemura

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

Goki Suda, Mineo Kudo, Atsushi Nagasaka et al. · Journal of Gastroenterology · 2016 · 109 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

Masatsugu Ohara, Koji Ogawa, Goki Suda et al. · Hepatology Communications · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling

Taku Shigesawa, Osamu Maehara, Goki Suda et al. · Carcinogenesis · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis

Naoki Kawagishi, Goki Suda, Akinobu Nakamura et al. · PLoS ONE · 2018 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C

Naoki Kawagishi, Goki Suda, Masahiro Onozawa et al. · Journal of Viral Hepatitis · 2017 · 46 citations

Pharmacy, Infectious Diseases, Pharmacology +14